MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-30-2026
Country |
 USA |
IPO year |
2000 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
155 M |
Market Cap[1] |
$ 25.5 B |
EBITDA (LTM) |
$ 1.07 B |
P/E (LTM) |
38.99 |
P/S (LTM) |
6.06 |
EPS (LTM) |
4.18 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 204.59 | 0.42 % | $ 22.7 B | NYSE,SPB | USA |
 |
Celcuity
CELC
|
$ 88.67 | -0.92 % | $ 4.15 B | Nasdaq Global Select Market | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Co-Diagnostics
CODX
|
$ 4.67 | -0.64 % | $ 6.21 M | Nasdaq Capital Market | USA |
 |
Fulgent Genetics
FLGT
|
$ 18.6 | -0.96 % | $ 572 M | Nasdaq Global Market | USA |
 |
Castle Biosciences
CSTL
|
$ 21.2 | 0.88 % | $ 615 M | Nasdaq Global Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 148.9 | -0.68 % | $ 11.7 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Guardant Health
GH
|
$ 130.03 | -0.66 % | $ 16.3 B | Nasdaq Global Select Market,SPB | USA |
 |
CareDx, Inc
CDNA
|
$ 23.55 | -0.49 % | $ 1.25 B | Nasdaq Global Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Interpace Biosciences
IDXG
|
$ 1.65 | -6.41 % | $ 7.3 M | Nasdaq Global Select Market | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 103.39 | -0.89 % | $ 6.98 B | Nasdaq Global Select Market,SPB | USA |
 |
Pacific Biosciences of California
PACB
|
$ 1.33 | -1.85 % | $ 399 M | Nasdaq Global Select Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 185.37 | -1.18 % | $ 9.19 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Medpace Holdings
MEDP
|
$ 475.25 | 0.04 % | $ 13.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 136.83 | -0.34 % | $ 23.4 B | NYSE,SPB |  Schweiz |
 |
NeoGenomics
NEO
|
$ 11.32 | -1.31 % | $ 1.45 B | Nasdaq Global Select Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 4.48 | -3.24 % | $ 415 M | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 18.51 | -1.49 % | $ 414 M | Nasdaq Global Select Market | USA |
 |
Natera
NTRA
|
$ 217.74 | -0.68 % | $ 29.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Personalis
PSNL
|
$ 9.44 | 0.26 % | $ 842 M | Nasdaq Global Select Market | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 26.12 | - | $ 24.8 B | NYSE |  Niderland |
 |
Twist Bioscience Corporation
TWST
|
$ 76.6 | 3.44 % | $ 4.58 B | Nasdaq Global Select Market,SPB | USA |
 |
Senseonics Holdings
SENS
|
$ 7.34 | 0.14 % | $ 306 M | NYSE American | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Biomerica
BMRA
|
$ 2.09 | - | $ 4.8 M | Nasdaq Capital Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 264.61 | -0.25 % | $ 22 B | NYSE,SPB | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 473.37 | -0.49 % | $ 178 B | NYSE,SPB | USA |
 |
Trinity Biotech plc
TRIB
|
$ 0.65 | -3.7 % | $ 233 M | Nasdaq Global Select Market | Irlanda |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Neogen Corporation
NEOG
|
$ 9.19 | -0.65 % | $ 1.99 B | Nasdaq Global Select Market,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.